Brief: Rezolute Initiates Phase 3 Clinical Study For RZ358 In Congenital Hyperinsulinism
14/12/2023 13:04
Dec 14 (Reuters) - Rezolute Inc RZLT.O :
* REZOLUTE INITIATES PHASE 3 CLINICAL STUDY FOR RZ358 IN
CONGENITAL HYPERINSULINISM
* REZOLUTE INC - ADDITIONAL SITES ARE BEING ACTIVATED ON A
REGULAR
BASIS OVER COMING WEEKS AND INTO BEGINNING OF 2024
Source text for Eikon: ID:nGNX1jS7rz
Further company coverage: RZLT.O
((Reuters.Briefs@thomsonreuters.com;))